Renal Arterial Resistive Index for Differential Diagnosis of Acute Kidney Injury

June 4, 2022 updated by: Bedriye Muge Sonmez, Ankara Diskapi Training and Research Hospital

Value of Renal Resistive Arterial Index for Differential Diagnosis of Patient With Anticipated Acute Kidney Injury Administered to Emergency Department

early differential diagnosis of anticipated acute kidney injury via ultrasound renal resistive index calculation

Study Overview

Status

Recruiting

Conditions

Detailed Description

acute kidney injury is a common clinical syndrome introducing to emergency services with varying symptoms. acute kidney injury is divided into 3 subgroups: prerenal, renal and postrenal. there is not any certain laboratory or imaging modality for early detection of injury's type. calculation of renal resistive index with doppler ultrasound at emergency setting can be helpful for early detection of etiology of acute kidney injury subgroup.patient will be selected according to clinical status and detailed history and laboratory parameters.renal resistive index will we calculated with doppler ultrasound of arcuate and interlober arteries of kidneys. resistive index values of acute kidney injury patients will be compared depending on further tests and resistive indexes of suggestive etiologies will be compared according to final diagnosis.

Study Type

Observational

Enrollment (Anticipated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: gülşen çığşar, assoc. prof.
  • Phone Number: 00905052874949
  • Email: gulakcay@yahoo.com

Study Locations

  • Turkey
      • Ankara, Turkey, 06110
        • Recruiting
        • Diskapi Research and Training Hospital
        • Contact:
        • Sub-Investigator:
          • gülşen çığşar, assoc. prof
        • Principal Investigator:
          • bedriye müge sönmez, assoc. prof
        • Sub-Investigator:
          • mustafa arslan, resident
        • Sub-Investigator:
          • melih gökçimen, resident
        • Sub-Investigator:
          • ilker şirin, resident

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

patient administering to emergency service with acute kidney injury independent of etiology

Description

Inclusion Criteria:

  1. age over 18
  2. patient with acute kidney injury diagnosed according to KDIGO, AKIN or RIFLE criteria

Exclusion Criteria:

  1. end stage kidney disease
  2. patients receiving renal replacement treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
increased resistive index
Time Frame: time spent at emergency service until renal doppler is done and resisitive index is calculated (6 hours)
differential diagnosis of acute kidney injury using renal doppler ultrasound and resistive index and comparison of subgroups
time spent at emergency service until renal doppler is done and resisitive index is calculated (6 hours)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
mortality
Time Frame: mortality at 7 days
mortality
mortality at 7 days
mortality
Time Frame: mortality at 28 days
mortality
mortality at 28 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Ankara Diskapi Training and Research Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 10, 2022

Primary Completion (Anticipated)

November 10, 2022

Study Completion (Anticipated)

November 10, 2022

Study Registration Dates

First Submitted

June 4, 2022

First Submitted That Met QC Criteria

June 4, 2022

First Posted (Actual)

June 8, 2022

Study Record Updates

Last Update Posted (Actual)

June 8, 2022

Last Update Submitted That Met QC Criteria

June 4, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • AnkaraDiskapiTRHAKI

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Kidney Injury

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Turkmenistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe